THESEUS PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
THESEUS PHARMACEUTICALS, INC. reported Proceeds from Common Stock Issued of $49.44 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00.
- THESEUS PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $0.00.
- THESEUS PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $49.44M.
- THESEUS PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $182.00K.
- THESEUS PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2022 was $182.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $0.00 derived: sum of 2 quarters · filed 2023-11-17 | $49.44M 10-Q · filed 2023-11-17 | $49.62M derived: sum of 4 quarters · filed 2023-11-17 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $49.44M 10-Q · filed 2023-08-10 | $49.62M derived: sum of 3 quarters · filed 2023-08-10 | $49.62M derived: sum of 4 quarters · filed 2023-11-17 | ||
| 2023-03-31 | $49.44M 10-Q · filed 2023-05-11 | $49.62M derived: sum of 2 quarters · filed 2023-05-11 | $49.62M derived: sum of 3 quarters · filed 2023-11-17 | $49.62M derived: sum of 4 quarters · filed 2023-11-17 | ||
| 2022-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $182.00K derived: sum of 2 quarters · filed 2023-11-17 | $182.00K derived: sum of 3 quarters · filed 2023-11-17 | $182.00K 10-K · filed 2023-03-09 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $0.00 derived: sum of 2 quarters · filed 2023-11-17 | $0.00 10-Q · filed 2023-11-17 | $70.00K 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $70.00K 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |